FCI Effectiveness in NAFLD Stratification - Trial NCT05827432
Access comprehensive clinical trial information for NCT05827432 through Pure Global AI's free database. This phase not specified trial is sponsored by NHS Grampian and is currently Not yet recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
NHS Grampian
Timeline & Enrollment
N/A
May 01, 2023
Mar 01, 2024
Primary Outcome
Differentiation of NAFLD types, from steatosis to liver fibrosis, assessed by Field-Cycling Imaging (FCI) scan
Summary
The goal of this pilot study is exploring whether field-cycling imaging may be able to detect
 characteristics of liver disease in patients with different degree of non-alcoholic fatty
 liver disease (NAFLD) that could be important in reflecting disease progression.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05827432
Device Trial